Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20020193869 A1
Publication typeApplication
Application numberUS 10/216,963
Publication dateDec 19, 2002
Filing dateAug 12, 2002
Priority dateDec 30, 1999
Also published asUS6471721
Publication number10216963, 216963, US 2002/0193869 A1, US 2002/193869 A1, US 20020193869 A1, US 20020193869A1, US 2002193869 A1, US 2002193869A1, US-A1-20020193869, US-A1-2002193869, US2002/0193869A1, US2002/193869A1, US20020193869 A1, US20020193869A1, US2002193869 A1, US2002193869A1
InventorsKenny Dang
Original AssigneeKenny Dang
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Vascular stent having increased radiopacity and method for making same
US 20020193869 A1
Abstract
A stent for use in a patient's blood vessel to maintain the patency of the vessel contains strategically located radiopaque material. The strategic placement of the radiopaque material in the core structure of the stent functions to enhance the resolution of the stent under fluoroscopy. The initial part of the process includes forming a groove in a piece of tube stock and securing radiopaque material into the groove by press fitting or diffusion bonding. After the securing method, a layer of material can be sputtered coated over the only radiopaque material or over the entire stent. Finally, a pattern of struts and splines is cut into the tube composite to form the stent.
Images(3)
Previous page
Next page
Claims(27)
What is claimed:
1. A method for forming a vascular stent having increased radiopacity, comprising the steps of:
selecting a tube of structural material;
forming at least one groove along the tube;
inserting radiopaque material into the groove;
securing said radiopaque material to the tube;
cutting the tube into a particular pattern to form spines and struts of a stent.
2. The method of claim 1, wherein:
the tube of structural material is formed of a biocompatible material selected from the group consisting of stainless steel, nickel-titanium alloys, and cobalt-based alloys.
3. The method of claim 1, wherein:
the step of forming the groove comprises forming one continuous groove.
4. The method of claim 1, wherein:
the radiopaque material is formed in a strip and the step of inserting the radiopaque material comprises inserting the strip into the groove.
5. The method of claim 1, wherein:
the method of claim 1, wherein the step of securing the radiopaque material includes the step of laser binding the radiopaque material into the groove.
6. The method of claim 4, wherein:
the step of securing the strip includes press-fitting the strip into the groove.
7. The method of claim 4, wherein:
the step of securing the strip includes the step of diffusion bonding the strip into the groove.
8. The method of claim 4, wherein:
the step of forming the groove comprises forming a plurality of grooves.
9. The method of claim 8, wherein:
a plurality of strips of radiopaque material are inserted into the plurality of grooves.
10. The method of claim 1, wherein:
the step of securing the radiopaque material into the groove includes press-fitting the material into the groove.
11. The method of claim 1, wherein:
the step of securing the radiopaque material includes the step of diffusion bonding the material into the groove.
12. The method of claim 1 wherein:
the grooves are formed as a plurality of rings.
13. The method of claim 1, wherein:
the cutting step is performed by a laser.
14. The method of claim 1, wherein:
the step of forming the grooves includes forming them on the exterior of the tube.
15. The method of claim 1, further including the step of:
sputter coating a layer of metal over the exterior surface of the radiopaque material.
16. The method of claim 1, wherein:
the step of forming the grooves includes forming them on the exterior of the tube in a selected pattern.
17. The method of claim 16, wherein:
the step of cutting the tube is performed in a pattern which selectively places radiopaque material on particular struts or spines of the finished stent.
18. A stent having enhanced radiopacity, comprising:
a tubular section constructed of at least one segment of a tube;
the segment having at least one groove formed therein;
a radiopaque material disposed within the groove; and
means for securing the material within the groove.
19. The stent of claim 18, wherein:
the means for securing the radiopaque material in the groove includes sputter coating a layer of metal over the radiopaque material.
20. The stent of claim 18, wherein:
the segment includes a target area; and
the groove is formed in selective patterns in the target area.
21. The stent of claim 18, wherein:
the segment is formed with one groove along a longitudinal line and the radiopaque material is located in the groove.
22. The stent of claim 18 wherein:
the means for securing the radiopaque material within the groove includes press fitting the material into the groove.
23. The stent of claim 18, wherein:
the means for securing the radiopaque material within the groove includes diffusion bonding the material into the groove.
24. The stent of claim 18, wherein:
the segment is formed with a plurality of grooves and the radiopaque material is formed in strips which are placed within the grooves.
25. The stent of claim 18 wherein:
the means for securing the radiopaque material within the grooves includes press fitting the strips of radiopaque material into the grooves.
26. The stent of claim 18, wherein:
the means for securing the radiopaque material within the grooves includes diffusion bonding the strips of radiopaque material into the grooves.
27. The stent of claim 18, wherein:
the means for securing the radiopaque material in the grooves includes sputter coating a layer of metal over the strips of radiopaque material.
Description
    BACKGROUND OF THE INVENTION
  • [0001]
    The present invention relates to improvements in increasing the radiopacity of stents and improvements in their method of manufacture, and more particularly, to a stent and a method of manufacture where radiopaque material is secured to strategic location(s) on the stent to improve visibility of the stent under fluoroscopy.
  • [0002]
    Generally, stents are expandable endoprosthesis devices which are adapted to be implanted into a patient's body lumen to maintain the patency of the vessel. Stents are especially well-suited for the treatment of atherosclerotic stenosis in blood vessels. These devices are typically implanted into blood vessels by a delivery catheter which is inserted at an easily accessible location and then advanced through the patient's vasculature to the deployment site. The stent is initially maintained in a radially compressed or collapsed state to enable it to be maneuvered through the lumen. Once in position, the stent is usually deployed either automatically by the removal of a restraint, or actively by the inflation of an expandable member, such as balloon, about which the stent is mounted on the delivery catheter.
  • [0003]
    The stent must be able to satisfy a number of mechanical requirements. First, the stent must be capable of withstanding the structural loads that are imposed by the vessel walls. In addition to having adequate radial strength, the stent should be longitudinally flexible to allow it to be maneuvered through a vascular path and to enable it to conform to a deployment site which may not be linear or may flex. The stent material must allow the stent to undergo expansion which typically requires substantial deformation of localized portions of the stent's structure. Once expanded, the stent must maintain its size and shape throughout its service life despite the various forces that may come to bear thereon, including the cyclic loading induced by the beating heart. Finally, the stent must be biocompatible so as not to trigger any adverse vascular responses.
  • [0004]
    Fluoroscopy is typically used to facilitate the precise placement of a stent as well as to verify the position of a stent within the patient throughout the stent's service life. The use of radiopaque materials in the construction of the stent allows for its direct visualization. Accordingly, different patterns and contents of radiopactivity have different effects on the direct visualization. For example, when a physician views a completely radiopaque stent under fluoroscopy, he/she will likely see an unclear and amorphous shape that extends outside the dimensions of the actual stent. The opposite will also be true where the stent possesses little radiopacity. In terms of fluoroscopic visibility, the optimal stent should be visible in a clear and detailed form without shape blurring. To date, no single material has been identified that simultaneously satisfies all requirements inherent in an optimal stent application. Those materials that do satisfy the mechanical requirements are either insufficiently or excessively radiopaque and/or are not adequately proven to be biocompatible in a vascular setting. Thus, simply constructing a stent which exhibits optimal radiopacity wholly out of a single material is not currently a viable option. A number of different approaches have, however, been employed wherein different materials are combined in an effort to render a mechanically sound and biocompatible stent to be visualized by a fluoroscope.
  • [0005]
    One procedure frequently used for accomplishing fluoroscopic visibility is through physical attachment of radiopaque markers to the stent. Conventional radiopaque markers, however, have a number of limitations. When attached to a stent, such markers may project from the surface of the stent, thereby exhibiting a departure from the ideal profile of the stent. Depending on their specific location, the marker may either project inwardly tending to disrupt blood flow or outwardly tending to traumatize the walls of the blood vessel. Additionally, when the metal used for the stent structure comes in contact with the metal used for the radiopaque marker, galvanic corrosion may occur. This corrosion may lead to separation of the metals and thereafter contamination of the blood stream with radiopaque material. Additionally, the radiopaque material may come into direct contact with living tissue which may be problematic, particularly if the material is not biocompatible.
  • [0006]
    Stents can also be marked by plating selected portions thereof with radiopaque material. A number of disadvantages with this approach are apparent. Because the radiopaque material comes into direct contact with living tissue, there can be a sizeable amount of tissue exposure. Additionally, when the stent is expanded and certain portions undergo substantial deformation, there is a risk that cracks will form in the plating which can separate from the underlying substrate. This side effect has the potential for creating jagged edges on the stent which may inflict trauma on the vessel wall or cause turbulence in the blood flow thereby inducing thrombogenesis. Moreover, once the underlying structural material becomes exposed, interfaces between the two disparate metals become subject to the same type of galvanic corrosion as mentioned above. Further, should the plating pattern cover less than all of the stent's surfaces, the margins between the plated and unplated regions are all subject to galvanic corrosion.
  • [0007]
    As a further alternative, a stent structure can be formed from a sandwich of structural and radiopaque materials. Tubes of suitable materials can be cold-drawn and heat treated to create a multi-layered tubing which can be cut into a stent. Struts and spines are formed in the multi layered tubing by cutting an appropriate pattern of voids into the tubing using well known techniques in the art. While this approach does provide a stent that has enhanced radiopacity and techniques fulfills necessary mechanical requirements, the thin cross section of the radiopaque material is usually exposed along the edges of all cut lines. The biocompatiblity of the radiopaque material remains an issue and more significantly, a sizeable area is created which is subject to galvanic corrosion. Any cuts in the sandwich structure cause two disparate metal interfaces, i.e. the juncture between the outer structural layer and the central radiopaque layer, as well the juncture between the central radiopaque layer and the inner structural layer, to become exposed to blood and tissue along the entire lengths of these cuts.
  • [0008]
    A stent configuration that overcomes the shortcomings inherent in previously known devices is therefore required. More specifically, a stent is needed that provides radiopaque properties enabling clear visibility under fluoroscopy and mechanical properties consistent for reliable and safe use.
  • [0009]
    A method of manufacturing the above mentioned stent configuration is also necessary. More specifically, a method is needed that combines the prerequisites of biocompatible materials and fluoroscopy into an advantageous method of manufacture.
  • SUMMARY OF INVENTION
  • [0010]
    The present invention provides a stent and method for manufacture which overcomes some of the shortcomings of previously known stents and methods of manufacturing stents. Most importantly, the stent has high resolution when viewed under fluoroscopy due to strategic placement of radiopaque material along the stent. The stent also fulfills the requirements of having sufficient flexibility, structural integrity and biocompatiblity, and being safe for deployment into a patient's vasculature.
  • [0011]
    Unique to the stent described herein is an advantageously selected pattern of radiopaque material formed on the stent. Compared to conventional stents, which are frequently obscured under fluoroscopy, the pattern of radiopaque material in the stent described herein leads to improved visibility under fluoroscopy. Unique to the process is a method of forming selected patterns of securely mounted radiopaque material on a stent substrate. Compared to some conventional processes of forming stents where radiopaque material is simply layered onto the stent structure, the process described herein utilizes a process of placing select patterns of grooves into the stent substrate. This grooving process allows precise placement and strong retention of radiopaque material into strategic locations of the stent.
  • [0012]
    The material employed for said underlying structure is selected for its structural and mechanical properties and may be the same general material used to make conventional stents. One preferred material is 316L stainless steel, although other materials such as nickel-titanium, cobalt based alloys, Nitinol and other types of stainless steel can be used. Such materials, when used in the 0.002″ to 0.003″ thickness, as is typical for stent applications, are often difficult to visualize fluoroscopically.
  • [0013]
    The grooving process is the first operation to be performed on a piece of tube stock. In this process, a pattern of groove(s), preferably either rings or lines, is cut in the tube stock. The grooves should be strategically placed at targeted locations along the length of the tubing to obtain the desired radiopacity. The stent may employ one or a multiple number of grooves depending on radiopacity requirements. In forming the groove(s), an instrument, such as a conventional Swiss screw machine can be used. Alternative machines can also be used to perform the same grooving operation.
  • [0014]
    After the grooving process is performed on the tube stock, radiopaque material is inserted into the groove(s) by either press-fitting, diffusion bonding or laser bonding. One preferred radiopaque material is gold, although other radiopaque materials such as platinum, tantalum, iridium, or their alloys can also be used. When press-fit, the shapes of the strip(s) must be in close conformance with the shape of the groove(s) while being slightly larger than the size of the groove(s). The radiopaque strip(s) are combined with the groove(s) in the tube such that the difference in sizing causes the two metals to lock together in an interference fit. The interference fit insures a strong and long lasting bond between the two materials. When the radiopaque strip(s) are diffusion bonded, an entirely different process of attachment can be employed. In the diffusion bonding procedure, a vacuum is drawn and the entire assembly (tubing with radiopaque material inserted into the groove(s)) is heated to near the particular diffusion bonding temperature with the bonding surfaces still exposed to the vacuum environment. Thereafter, the bonding surfaces are brought into contact with very moderate pressure and maintained at a temperature and pressure sufficient for diffusion bonding. The assembly is then cooled, resulting in a substantially unitary diffusion bonded structure.
  • [0015]
    While not mandatory for this process, stainless steel can be applied over the radiopaque sections of the tube to promote biocompatibility and structural integrity. Additionally, the stainless steel coating can act to protect the radiopaque and structural materials from galvanically corroding. The stainless steel, preferably 316L can be applied by a sputtering procedure, a method of depositing a metallic film through the use of electric discharge. Sputter coating machines are commercially available and capable of applying an extremely even coating of material to a workpiece. The tubing may be rotated in front of a nozzle, the nozzle may be rotated about the tubing or a nozzle that completely surrounds the tubing may be employed to apply the sputter coating. While the preferred material for the sputtering is 316L stainless steel, other suitable material can be used also. Additionally, if a higher degree of structural rigidity is sought, the material can be sputtered across the entire length of the tube to a sufficient thickness such that the structural integrity of the stent is significantly increased.
  • [0016]
    After the tube has been processed as described above, a procedure for cutting the tube can be initiated. In this procedure, for example, the tubing is first placed in a rotatable fixture inside a cutting machine, where it is positioned relative to a laser. According to machine encoded instructions, the tubing is rotated and moved longitudinally relative to the laser. The laser selectively removes the material from the tubing by ablation and a pattern is cut into the tube. The laser cut provides a desired pattern of voids defining struts and spines which allows the stent to expand in an even manner, in accordance with well known and well established procedures. Thereafter, the stents are subjected to the standard industry practices of electro-polishing and possibly annealing. Another biocompatible outer layer could also be applied to the stent.
  • [0017]
    The above and other objects and advantages of this invention will be apparent from the following more detailed description when taken in conjunction with the accompanying drawings of exemplary embodiments.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0018]
    [0018]FIG. 1 is a perspective view of the tube stock with one particular pattern of grooves cut into the tube in a ring-shaped pattern, constant in diameter, and spaced apart longitudinally.
  • [0019]
    [0019]FIG. 2 is a perspective view of the tube stock with radiopaque material inserted into the grooves and annularly bonded in a complementary fit.
  • [0020]
    [0020]FIG. 3 is a perspective view of the tube stock with radiopaque material inserted into grooves with sputtered material entirely covering the markers.
  • [0021]
    [0021]FIG. 4 is a perspective view of a portion of a stent which can be cut from the composite tube stock illustrated in FIGS. 1-4 and embodying features of the present invention.
  • [0022]
    [0022]FIG. 5 is a cross sectional view of a representative strut of a stent made in accordance with the present invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0023]
    A radiopaque stent and the process of forming said stent is described herein. Unique to the stent is an advantageously selected pattern of radiopaque material which is affixed to the stent. Compared to conventional stents which are frequently obscured under flouroscopy, the pattern of radiopaque material in the stent of the present invention allows an easily discernable view of the stent under fluoroscopy. Unique to the process of manufacturing the stent is a method of forming selected patterns of radiopacity within the stent. Compared to some conventional processes whereby radiopaque material is layered onto stent structures, the method of the present invention includes a grooving process which allows for precise location of radiopaque material into the core of the stent.
  • [0024]
    Referring now to the drawings, wherein like numerals indicate like elements, a representation stent 10 made in accordance with the present invention is shown in FIG. 4. The stent 10 can be made in any number of different strut patterns, depending on the particular application for the stent. The stent 10 is representative of just one design which can be used to form the various struts and spines. Referring now to FIG. 1, a piece of tube stock 11 to be used for the underlying structure of the stent is shown. The material employed for said underlying structure is selected for its structural and mechanical properties and may be the same material from which conventional stents are made. One preferred material is 316L stainless steel, although other materials such as nickel-titanium, cobalt based alloys, Nitinol and other types of stainless steel can be used. Such materials, when used in the 0.002″ to 0.003″ thickness which is typical for stent applications, are often difficult to properly visualize fluoroscopically.
  • [0025]
    As shown in FIG. 1, a series of grooves 12 may be formed in tube stock 11 by a Swiss screw machine operation, or other machinery. One preferred pattern of groove(s) is either ring(s) or line(s), but any other pattern can be used. Such grooves can be placed at targeted locations along the length of the tubing in order to obtain the desired radiopactivity along the stent. In addition, the number of grooves can vary according to the stent's application. For instance, if high radiopacity is required, a plurality of grooves can be formed along the tube stock. If low radiopacity is required, as little as one groove can be formed along the tube stock. While one preferred machine to form the grooves is a conventional Swiss screw machine, other machines can be used to perform the same grooving operation.
  • [0026]
    Referring now to FIG. 2, the tube stock 11 may incorporate radiopaque material 13 inserted into the grooves 12. The radiopaque material can be formed into strips which are placed into the grooves. One preferred radiopaque material is gold, although other radiopaque materials such but not limited to, platinum, tantalum, iridium, or their alloys can also be used. The strips are preferably inserted into the grooves by either a press-fit, diffusion bonding or laser bonding. When the strips are press-fit into the grooves, their shape must be in close conformance with, but slightly larger than, the width of the groove. The press fit ensures an interference between the radiopaque strips and the tube material which secures both materials together in a strong, long-lasting bond. If the strips are diffusion bonded to the tube, a different type of process is necessary. First, a vacuum is drawn and the assembly, which includes the tube and radiopaque strips placed in the grooves, is heated to near diffusion bonding temperature with the bonding surfaces still exposed to the vacuum environment. Thereafter, the bonding surfaces are brought into contact with very moderate pressure and are maintained at a temperature and pressure sufficient for diffusion bonding. The assembly is then cooled, resulting in a substantially unitary diffusion bonded structure. The advantageously selected patterns of radiopacity will allow precise orientation or degree of expansion to be discerned by inspection of the fluoroscopic image when the stent is completed.
  • [0027]
    Referring now to FIG. 3, the tubing 11 may incorporate radiopaque material 13 in the form described above with the addition of a thin layer of stainless steel 14 covering the radiopaque material. The stainless steel is applied to the tubing by sputtering, a method of depositing a metallic film through the use of electric discharge. Sputter coating machines are commercially available and capable of applying an extremely even coating of material to a workpiece. In practice, the tubing may be rotated in front of a nozzle, the nozzle may be rotated about the tubing or a nozzle that completely surrounds the tubing may be employed to apply the sputter coating. While one preferred material for the sputtering is 316L stainless steel, other suitable material can be also be used. In addition to securing the radiopaque strip(s) to the tubing, the sputtered layer of metal can function to prevent galvanic corrosion and strengthen the entire stent. In this regard, the material can be sputtered to a sufficient thickness over selected regions of the tube 11 or over the entire tube such that the structural integrity of the stent is significantly increased.
  • [0028]
    Referring now to FIG. 4, the composite radiopaque tubing 11 is illustrated with a substantial amount of material removed to passing the struts and spines of the stent 10. In the material removal procedure, the tubing is placed in a rotatable fixture of a cutting machine where it is positioned relative to a laser. The machine rotates and moves the tubing longitudinally relative to the laser, in accordance with machine encoded instructions. The laser selectively removes the material from the tubing by ablation and a pattern 14 is cut into the tube. The laser cut provides a desired pattern of voids defining struts and spines while leaving both the radiopaque strips 13 and sputtered stainless steel coating 14 in strategic locations. The tube is therefore cut into the discrete pattern of the finished stent. Further details on how the tubing can be cut by a laser are found in U.S. Pat. Nos. 5,759,192 (Saunders) and 5,780,807 (Saunders), which have been assigned to Advanced Cardiovascular Systems, Inc. and are incorporated herein by reference in their entirely.
  • [0029]
    [0029]FIG. 4 illustrates a portion of a representative stent 10 where the radiopaque strips 13 and the sputtered coating 14 are integral to the stent 10 and accompany the cut patterns 14. FIG. 5 shows a cross sectional view of a representative strut of the stent 10 made in accordance with the present invention which has a strategically located radiopaque material and a sputtered coating 14 affixed thereto. In a preferred embodiment, the placement of the radiopaque material on the stock tubing can be coordinated with the particular pattern of struts and spines which will be cut into the tube to ensure that the radiopaque material is completely surrounded by the tubing material once the tube is cut. Therefore, there should be no edges on a strut or spine which exposes the layer of radiopaque material directly to blood or tissue. The layer of coating which is sputtered onto the radiopaque material should complete the encapsulation of the radiopaque material. In this manner, the layers of material should not be exposed to possible elements which can cause galvanic corrosion or the layers to delaminate. Thereafter the stent is subjected to the standard industry practices of electro-polishing and possibly annealing. A biocompatable outer layer could also be added to the stent surface.
  • [0030]
    It should be appreciated that the radiopaque material may not be completely surrounded by tubing material and the layer of sputter coating in all instances. It is possible that some radiopaque material may be exposed on the sides of the stent struts after the tubing is cut. However, exposure of the radiopaque material can be kept at a minimum to help prevent galvanic corrosion from occurring and the risk of cracks forming along the struts. It is still possible to sputter an additional layer of coating onto the stent after it has been cut to assure that no edges of the struts expose radiopaque material directly to blood and tissue. In this manner, the radiopaque material on the stent can be fully encapsulated. Alternatively, a stent manufactured in accordance with the present invention can be made by first placing the radiopaque material into the grooves formed on the tubing and then cutting the struts and spines of the stent prior to any coating of the tubing. Thereafter, once the struts and spines of the stent have been properly formed, the thin layer of coating could then be placed on the stent to fully encapsulate the radiopaque material.
  • [0031]
    An advantage of the stent, and the method for manufacture described above, lies in the resolution of the stent under fluoroscopy. As previously mentioned, the high resolution is due to the strategically placed radiopaque strips inserted into grooves formed in the stent. The benefits of the stent are immediately apparent in practice where a physician, who views the stent under fluoroscopy, will clearly see the size and location of the stent in the vessel of the patient. The clear view of the stent enables the physician to perform his function efficiently and safely without the worry of incorrectly approximating the size or location of the stent.
  • [0032]
    While a particular form of the invention has been illustrated and described, it will also be apparent to those skilled in the art that various modifications can be made without departing from the spirit and scope of the invention. More specifically, it should be clear that the present invention is not limited to tubular type stents nor is it limited to any particular method of forming the underlying stent structure. Additionally, the invention is not limited to the use of any particular materials in either the core, radiopaque coating or encapsulating layer nor is it intended to be limited to any particular coating or application method. Accordingly, it is not intended that the invention be limited except by the appended claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US6379381 *Sep 3, 1999Apr 30, 2002Advanced Cardiovascular Systems, Inc.Porous prosthesis and a method of depositing substances into the pores
US6464720 *Mar 30, 2001Oct 15, 2002Cook IncorporatedRadially expandable stent
US6530951 *Oct 23, 1997Mar 11, 2003Cook IncorporatedSilver implantable medical device
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7854760May 16, 2005Dec 21, 2010Boston Scientific Scimed, Inc.Medical devices including metallic films
US7901447Mar 8, 2011Boston Scientific Scimed, Inc.Medical devices including a metallic film and at least one filament
US7931683Jul 27, 2007Apr 26, 2011Boston Scientific Scimed, Inc.Articles having ceramic coated surfaces
US7938855May 10, 2011Boston Scientific Scimed, Inc.Deformable underlayer for stent
US7942926Jul 11, 2007May 17, 2011Boston Scientific Scimed, Inc.Endoprosthesis coating
US7976915Jul 12, 2011Boston Scientific Scimed, Inc.Endoprosthesis with select ceramic morphology
US7981150Jul 19, 2011Boston Scientific Scimed, Inc.Endoprosthesis with coatings
US7985252Jul 30, 2008Jul 26, 2011Boston Scientific Scimed, Inc.Bioerodible endoprosthesis
US7998192Aug 16, 2011Boston Scientific Scimed, Inc.Endoprostheses
US8002821Aug 23, 2011Boston Scientific Scimed, Inc.Bioerodible metallic ENDOPROSTHESES
US8002823Jul 11, 2007Aug 23, 2011Boston Scientific Scimed, Inc.Endoprosthesis coating
US8029554Nov 2, 2007Oct 4, 2011Boston Scientific Scimed, Inc.Stent with embedded material
US8043364Aug 16, 2001Oct 25, 2011Angiomed Gmbh & Co. Medizintechnik KgImplant with attached element and method of making such an implant
US8048150Apr 12, 2006Nov 1, 2011Boston Scientific Scimed, Inc.Endoprosthesis having a fiber meshwork disposed thereon
US8052743Aug 2, 2007Nov 8, 2011Boston Scientific Scimed, Inc.Endoprosthesis with three-dimensional disintegration control
US8052744Sep 13, 2007Nov 8, 2011Boston Scientific Scimed, Inc.Medical devices and methods of making the same
US8052745Nov 8, 2011Boston Scientific Scimed, Inc.Endoprosthesis
US8057534Sep 14, 2007Nov 15, 2011Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8066758Dec 28, 2005Nov 29, 2011C. R. Bard, Inc.Vascular graft with kink resistance after clamping
US8066763May 11, 2010Nov 29, 2011Boston Scientific Scimed, Inc.Drug-releasing stent with ceramic-containing layer
US8067054Nov 29, 2011Boston Scientific Scimed, Inc.Stents with ceramic drug reservoir layer and methods of making and using the same
US8070797Dec 6, 2011Boston Scientific Scimed, Inc.Medical device with a porous surface for delivery of a therapeutic agent
US8071156Mar 4, 2009Dec 6, 2011Boston Scientific Scimed, Inc.Endoprostheses
US8080055Dec 20, 2011Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8089029Feb 1, 2006Jan 3, 2012Boston Scientific Scimed, Inc.Bioabsorbable metal medical device and method of manufacture
US8128689Sep 14, 2007Mar 6, 2012Boston Scientific Scimed, Inc.Bioerodible endoprosthesis with biostable inorganic layers
US8152841Apr 23, 2010Apr 10, 2012Boston Scientific Scimed, Inc.Medical devices including metallic films
US8187620May 29, 2012Boston Scientific Scimed, Inc.Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8216632Jul 10, 2012Boston Scientific Scimed, Inc.Endoprosthesis coating
US8221822Jul 30, 2008Jul 17, 2012Boston Scientific Scimed, Inc.Medical device coating by laser cladding
US8231980Jul 31, 2012Boston Scientific Scimed, Inc.Medical implants including iridium oxide
US8236046Jun 10, 2008Aug 7, 2012Boston Scientific Scimed, Inc.Bioerodible endoprosthesis
US8267992Sep 18, 2012Boston Scientific Scimed, Inc.Self-buffering medical implants
US8287937Apr 24, 2009Oct 16, 2012Boston Scientific Scimed, Inc.Endoprosthese
US8292950 *Feb 21, 2008Oct 23, 2012C. R. Bard, Inc.Stent with radiopaque marker
US8303643Nov 6, 2012Remon Medical Technologies Ltd.Method and device for electrochemical formation of therapeutic species in vivo
US8313524Aug 30, 2005Nov 20, 2012C. R. Bard, Inc.Self-sealing PTFE graft with kink resistance
US8322593Aug 14, 2007Dec 4, 2012C. R. Bard, Inc.Method of welding a component to a shape memory alloy workpiece with provision of an extra cut for compensating the variations of dimension of workpiece and component
US8353949Sep 10, 2007Jan 15, 2013Boston Scientific Scimed, Inc.Medical devices with drug-eluting coating
US8382824Oct 3, 2008Feb 26, 2013Boston Scientific Scimed, Inc.Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8425589Apr 23, 2013Admedes Schuessler GmbhMechanical locking of an X-ray marker in the eyelet of a stent or in another bodily implant
US8431149Apr 30, 2013Boston Scientific Scimed, Inc.Coated medical devices for abluminal drug delivery
US8449603May 28, 2013Boston Scientific Scimed, Inc.Endoprosthesis coating
US8475519Aug 16, 2006Jul 2, 2013Admedes Schuessler GmbhX-ray visibility and corrosion resistance of niti stents using markers made of sandwich material
US8475520 *Dec 5, 2007Jul 2, 2013C. R. Bard, Inc.Stenting ring with marker
US8500793Sep 7, 2007Aug 6, 2013C. R. Bard, Inc.Helical implant having different ends
US8518101Apr 3, 2008Aug 27, 2013C. R. Bard, Inc.Bendable stent
US8551156Nov 9, 2007Oct 8, 2013C. R. Bard, Inc.Stent
US8574286May 18, 2007Nov 5, 2013C. R. Bard, Inc.Bend-capable stent prosthesis
US8574615May 25, 2010Nov 5, 2013Boston Scientific Scimed, Inc.Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8591568Dec 29, 2004Nov 26, 2013Boston Scientific Scimed, Inc.Medical devices including metallic films and methods for making same
US8632580Dec 29, 2004Jan 21, 2014Boston Scientific Scimed, Inc.Flexible medical devices including metallic films
US8636794Nov 9, 2006Jan 28, 2014C. R. Bard, Inc.Grafts and stent grafts having a radiopaque marker
US8652284Nov 21, 2011Feb 18, 2014C. R. Bard, Inc.Vascular graft with kink resistance after clamping
US8668732Mar 22, 2011Mar 11, 2014Boston Scientific Scimed, Inc.Surface treated bioerodible metal endoprostheses
US8715339Nov 21, 2011May 6, 2014Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8721709Sep 5, 2008May 13, 2014C. R. Bard, Inc.Self-expansible stent with radiopaque markers and method of making such a stent
US8728563May 3, 2011May 20, 2014Palmaz Scientific, Inc.Endoluminal implantable surfaces, stents, and grafts and method of making same
US8771343Jun 15, 2007Jul 8, 2014Boston Scientific Scimed, Inc.Medical devices with selective titanium oxide coatings
US8808726Sep 14, 2007Aug 19, 2014Boston Scientific Scimed. Inc.Bioerodible endoprostheses and methods of making the same
US8815273Jul 27, 2007Aug 26, 2014Boston Scientific Scimed, Inc.Drug eluting medical devices having porous layers
US8815275Jun 28, 2006Aug 26, 2014Boston Scientific Scimed, Inc.Coatings for medical devices comprising a therapeutic agent and a metallic material
US8834559Feb 28, 2006Sep 16, 2014Admedes Schuessler GmbhStent
US8840660Jan 5, 2006Sep 23, 2014Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8864815Feb 22, 2011Oct 21, 2014Boston Scientific Scimed, Inc.Medical devices including metallic film and at least one filament
US8900290Oct 21, 2011Dec 2, 2014Angiomed Gmbh & Co. Medizintechnik KgImplant with attached element and method of making such an implant
US8900292Oct 6, 2009Dec 2, 2014Boston Scientific Scimed, Inc.Coating for medical device having increased surface area
US8920491Apr 17, 2009Dec 30, 2014Boston Scientific Scimed, Inc.Medical devices having a coating of inorganic material
US8932346Apr 23, 2009Jan 13, 2015Boston Scientific Scimed, Inc.Medical devices having inorganic particle layers
US8992592Dec 29, 2004Mar 31, 2015Boston Scientific Scimed, Inc.Medical devices including metallic films
US8998973Dec 29, 2004Apr 7, 2015Boston Scientific Scimed, Inc.Medical devices including metallic films
US9050203Aug 23, 2013Jun 9, 2015C. R. Bard, Inc.Bendable stent
US9084691Oct 3, 2013Jul 21, 2015C. R. Bard, Inc.Stent
US9155491Jan 23, 2014Oct 13, 2015C.R. Bard, Inc.Grafts and stent grafts having a radiopaque marker
US9155642Mar 22, 2013Oct 13, 2015C.R. Bard, Inc.Bend-capable tubular prosthesis
US9198749Oct 12, 2007Dec 1, 2015C. R. Bard, Inc.Vascular grafts with multiple channels and methods for making
US9254207Aug 28, 2007Feb 9, 2016C.R. Bard, Inc.Annular mesh
US9284409Jul 17, 2008Mar 15, 2016Boston Scientific Scimed, Inc.Endoprosthesis having a non-fouling surface
US9364353Nov 1, 2013Jun 14, 2016C.R. Bard, Inc.Bend-capable stent prosthesis
US20040015228 *Aug 16, 2001Jan 22, 2004Sylvie LombardiImplant with attached element and method of making such an implant
US20060217799 *Feb 28, 2006Sep 28, 2006Admedes Schuessler GmbhStent
US20060259129 *Apr 26, 2006Nov 16, 2006Admedes Schuessler GmbhMechanical locking of an X-ray marker in the eyelet of a stent or in another bodily implant
US20070043429 *Aug 16, 2006Feb 22, 2007Admedes Schuessler GmbhX-ray visibility and corrosion resistance of niti stents using markers made of sandwich material
US20090171436 *Nov 9, 2006Jul 2, 2009Casanova R MichaelGrafts and stent grafts having a radiopaque beading
US20090200360 *Aug 14, 2007Aug 13, 2009C.R. Bard, Inc.Method of welding a component to a shape memory alloy workpiece with provision of an extra cut for compensating the variations of dimension of workpiece and component
US20090204201 *May 18, 2007Aug 13, 2009C. R. Bard, Inc.Bend-capable stent prosthesis
US20100004725 *Sep 7, 2007Jan 7, 2010C. R. Bard, Inc.Helical implant having different ends
US20100016949 *Aug 28, 2007Jan 21, 2010C.R.Bard, Inc.Annular mesh
US20100070018 *Jul 10, 2007Mar 18, 2010Angiomed Gmbh & Co. Medizintechnik KgTubular Metal Prosthesis and Method of Making It
US20100070021 *Dec 5, 2007Mar 18, 2010C.R. Bard, IncStenting Ring with Marker
US20100114298 *Feb 21, 2008May 6, 2010C.R. Bard, Inc.Stent with radiopaque marker
US20100191321 *Sep 5, 2008Jul 29, 2010C.R. Bard ,Inc.Self-expansible stent with radiopaque markers and method of making such a stent
US20100211161 *Apr 3, 2008Aug 19, 2010C. R. Bard, Inc.Bendable Stent
US20100249903 *Nov 9, 2007Sep 30, 2010C. R. Bard, Inc.Stent
USRE44463Aug 16, 2001Aug 27, 2013Angiomed Gmbh & Co. Medizintechnik KgImplant with attached element and method of making such an implant
DE102005039136B4 *Aug 18, 2005Jul 28, 2011Admedes Schuessler GmbH, 75179Verbesserung der Röntgensichtbarkeit und Korrosionsbeständigkeit von NiTi Stents unter Einsatz von Nieten aus Sandwichmaterial
WO2007056762A2 *Nov 9, 2006May 18, 2007C.R. Bard Inc.Grafts and stent grafts having a radiopaque beading
WO2012151405A2 *May 3, 2012Nov 8, 2012Palmaz Scientific, Inc.Endoluminal implantable surfaces and method of making the same
WO2012151405A3 *May 3, 2012Jan 17, 2013Palmaz Scientific, Inc.Endoluminal implantable surfaces and method of making the same
Classifications
U.S. Classification623/1.15, 623/1.34
International ClassificationA61F2/82, A61F2/00
Cooperative ClassificationA61F2002/91558, A61F2002/91533, A61F2002/825, A61F2/91, A61F2/915, A61F2230/0013, A61F2250/0098
European ClassificationA61F2/91, A61F2/915